00460.HK
Sihuan Pharmaceutical Holdings Group Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.71
−2.07%Margins
Gross margin
65.6%
EBITDA margin
26.5%
EBIT margin
24.9%
Net margin
11.5%
FCF margin
-3.6%
4.9%
Return on equity
2.6%
Return on assets
9.2%
Return on invested capital
0.23x
Asset turnover
-HKD 18.8M
Cash from operations
HKD 0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026